More importantly, the significant correlation between STAT expressions and immunotherapy response-associated indicators showed that they had the potential to predict response to immunotherapy in patients with CRC and could be used to assist the physician in deciding on a therapeutic regimen. Here, SOAT1 is linked to colorectal carcinoma.